Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02830451 · ClinicalTrials.gov registry record
Metastatic Tumor Research and Outcomes Network
A clinical trial of Metastatic Spine Tumor, sponsored by AO Innovation Translation Center.
- Active
- Registry status
- 960
- Enrollment target
- 20
- Study locations
NCT02830451: Active study of Metastatic Spine Tumor, sponsored by AO Innovation Translation Center.
NCT02830451 is a study of Metastatic Spine Tumor that is active but no longer recruiting, run by AO Innovation Translation Center. The registered enrollment target is 960 participants. The trial reports 20 study locations across 18 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02830451, a study of Metastatic Spine Tumor, is active but no longer recruiting, sponsored by AO Innovation Translation Center.
- ACTIVE NOT RECRUITING
- Registry status
- 960 participants
- Enrollment target
- 20
- Study locations
Study Summary
The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
Primary Outcome
The following patient data will be collected: * gender, year of birth, height, weight, race * work status, education level, marital status * smoking, alcohol and recreational drug use * medication use * nutrition and vitamin intake * presence of osteoporosis * comorbidities according to the Charlson Comorbidity Index - CCI
Conditions Studied
Study Locations (20)
New York
- Memorial Sloan-Kettering Cancer Center - New York
- University of Rochester School of Medicine and Dentistry Department of Orthopaedic Surgery and Neurosurgery - Rochester
Ontario
- Toronto Western Hospital Department of Neurosurgery Division of Surgery - Toronto
- University of Toronto Odette Cancer Centre - T2 158 Sunnybrook Health Sciences Ccenter - Toronto
California
- University of California The UCSF Spine Center Department of Neurological Surgery - San Francisco
Illinois
- Rush University Medical Center University Neurosurgery - Chicago
Maryland
- Johns Hopkins University Department of Neurosurgery / Spine Division - Baltimore
Massachusetts
- Harvard Medical School Department of Neurosurgery - Boston
Minnesota
- Mayo Clinic Department of Neurosurgery - Rochester
Pennsylvania
- Penn Presbyterian Medical Center Department of Neurosurgery - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 960 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2026-08-15 |
What the registry record for NCT02830451 still lists
NCT02830451 is an observational study that tracks outcomes without assigning an intervention. The registered 960 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Metastatic Spine Tumor appearing as the primary indexed condition, and to 0 interventions.
NCT02830451 names 20 study sites across 18 states, led by New York, Ontario, California.
Frequently Asked Questions
What is clinical trial NCT02830451 about?
NCT02830451 is a clinical study titled "Metastatic Tumor Research and Outcomes Network". The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
What is the current status of trial NCT02830451?
This trial is currently active not recruiting. The enrollment target is 960 participants. The study started on 2017-11-15. Estimated completion is 2026-08-15.
What conditions does trial NCT02830451 study?
This clinical trial studies the following conditions: Metastatic Spine Tumor.
Who is sponsoring clinical trial NCT02830451?
This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02830451 being conducted?
This trial has 20 study locations across California, Illinois, Maryland, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- NCT05142384 · 960 participants · NA
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
- NCT05178498 · 960 participants
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
- NCT05946629 · 960 participants · NA
SELUTION 4 De Novo Small Vessel IDE Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI